Promotion of Hendra virus replication by microRNA 146a

Journal of Virology

Volumn 87, Issue 7, 2013, Pages 3782-3791

  Stewart, Cameron R ^a   Marsh, Glenn A ^a   Jenkins, Kristie A ^a   Gantier, Michael P ^b   Tizard, Mark L ^a   Middleton, Deborah ^a   Lowenthal, John W ^a   Haining, Jessica ^a   Izzard, Leonard ^a,c   Gough, Tamara J ^a   Deffrasnes, Celine ^a   Stambas, John ^a,c   Robinson, Rachel ^a   Heine, Hans G ^a   Pallister, Jackie A ^a   Foord, Adam J ^a   Bean, Andrew G ^a   Wang, Lin Fa ^a  

^a CSIRO   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 146A; RING FINGER PROTEIN; RING FINGER PROTEIN 11; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; COMPUTER MODEL; CONTROLLED STUDY; FERRET; GENETIC TRANSFECTION; HELA CELL; HENDRA VIRUS; HENDRA VIRUS INFECTION; HORSE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE; UPREGULATION; VIRUS REPLICATION;

CARRIER PROTEINS; CLONING, MOLECULAR; HELA CELLS; HENDRA VIRUS; HUMANS; I-KAPPA B PROTEINS; MICRORNAS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRUS REPLICATION;

EQUIDAE; HENDRA VIRUS; HENIPAVIRUS; MUSTELA; PARAMYXOVIRIDAE;

EID: 84875549860     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01342-12     Document Type: Article

References (52)

1. Murray K, Selleck P, Hooper P, Hyatt A, Gould A, Gleeson L, Westbury H, Hiley L, Selvey L, Rodwell B, et al. 1995. A morbillivirus that caused fatal disease in horses and humans. Science 268:94 -97.
2. Halpin K, Young PL, Field HE, Mackenzie JS. 2000. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J. Gen. Virol. 81:1927-1932.
3. Anonymous. 6 January 2012, posting date. Hendra virus, equine - Australia: (Queensland). ProMED-mail, 20120106.1001359. http://www.promedmail .org/direct.php?id 20120106.1001359.
4. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
5. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843- 854.
6. Meister G, Tuschl T. 2004. Mechanisms of gene silencing by doublestranded RNA. Nature 431:343-349.
7. Tomari Y, Zamore PD. 2005. Perspective: machines for RNAi. Genes Dev. 19:517-529.
8. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-1581.
9. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H. 2010. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327:198 -201.
10. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10:111-122.
11. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, Sun G, Tay J, Linsley PS, Baltimore D. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208:1189 -1201.
12. Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103:12481-12486.
13. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK. 2008. Epstein-Barr virus latent membrane protein 1 induces cellular microRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 82:1946 -1958.
14. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183:2150 -2158.
15. Marsh GA, Haining J, Hancock TJ, Robinson R, Foord AJ, Barr JA, Riddell S, Heine HG, White JR, Crameri G, Field HE, Wang LF, Middleton D. 2011. Experimental infection of horses with Hendra virus/ Australia/horse/2008/Redlands. Emerg. Infect. Dis. 17:2232-2238.
16. Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, Chan YP, Broder CC. 2011. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine 29:5623-5630.
17. Shi R, Chiang VL. 2005. Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 39:519 -525.
18. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, Zingale A, Baccarini A, Lazzari G, Galli C, Naldini L. 2007. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25:1457-1467.
19. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. 2009. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 15:31-33.
20. Feldman KS, Foord A, Heine HG, Smith IL, Boyd V, Marsh GA, Wood JL, Cunningham AA, Wang LF. 2009. Design and evaluation of consensus PCR assays for henipaviruses. J. Virol. Methods 161:52-57.
21. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hygiene. 27:493- 497.
22. Gantier MP, Stunden HJ, McCoy CE, Behlke MA, Wang D, Kaparakis- Liaskos M, Sarvestani ST, Yang YH, Xu D, Corr SC, Morand EF, Williams BR. 2012. A miR-19 regulon that controls NF-kappaB signaling. Nucleic Acids Res. 40:8048-8058.
23. DiDonato JA, Mercurio F, Karin M. 1995. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol. Cell. Biol. 15:1302-1311.
24. Laurie KL, Carolan LA, Middleton D, Lowther S, Kelso A, Barr IG. 2010. Multiple infections with seasonal influenza A virus induce crossprotective immunity against A(H1N1) pandemic influenza virus in a ferret model. J. Infect. Dis. 202:1011-1020.
25. Wang L, Harcourt BH, Yu M, Tamin A, Rota PA, Bellini WJ, Eaton BT. 2001. Molecular biology of Hendra and Nipah viruses. Microbes Infect. 3:279 -287.
26. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730 -737.
27. Liu X, Erikson RL. 2003. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100:5789 -5794.
28. Jacque E, Ley SC. 2009. RNF11, a new piece in the A20 puzzle. EMBO J. 28:455- 456.
29. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME. 1997. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:21096 -21103.
30. Lee DH, Goldberg AL. 1998. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8:397- 403.
31. Virtue ER, Marsh GA, Wang LF. 2011. Interferon signaling remains functional during henipavirus infection of human cell lines. J. Virol. 85: 4031-4034.
32. Ciancanelli MJ, Volchkova VA, Shaw ML, Volchkov VE, Basler CF. 2009. Nipah virus sequesters inactive STAT1 in the nucleus via a P geneencoded mechanism. J. Virol. 83:7828 -7841.
33. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. 2005. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J. Virol. 79: 6078-6088.
34. Levy DE, Marie IJ. 2004. RIGging an antiviral defense-it's in the CARDs. Nat. Immunol. 5:699 -701.
35. Shembade N, Parvatiyar K, Harhaj NS, Harhaj EW. 2009. The ubiquitin- editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling. EMBO J. 28:513-522.
36. Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, and Baltimore D. 2011. NF-kappaB dysregulation in microRNA-146adeficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. U. S. A. 108:9184 -9189.
37. Algarte M, Nguyen H, Heylbroeck C, Lin R, Hiscott J. 1999. IkappaBmediated inhibition of virus-induced beta interferon transcription. J. Virol. 73:2694 -2702.
38. Fiedler MA, Wernke-Dollries K. 1999. Incomplete regulation of NFkappaB by IkappaBalpha during respiratory syncytial virus infection in A549 cells. J. Virol. 73:4502- 4507.
39. Cahir McFarland ED, Izumi KM, Mosialos G. 1999. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 18:6959-6964.
40. Marusawa H, Hijikata M, Chiba T, Shimotohno K. 1999. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J. Virol. 73:4713- 4720.
41. Schwarz EM, Badorff C, Hiura TS, Wessely R, Badorff A, Verma IM, Knowlton KU. 1998. NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J. Virol. 72:5654 -5660.
42. Marianneau P, Cardona A, Edelman L, Deubel V, Despres P. 1997. Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J. Virol. 71:3244 -3249.
43. Griffin GE, Leung K, Folks TM, Kunkel S, Nabel GJ. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature 339:70 -73.
44. Santhakumar D, Forster T, Laqtom NN, Fragkoudis R, Dickinson P, Abreu-Goodger C, Manakov SA, Choudhury NR, Griffiths SJ, Vermeulen A, Enright AJ, Dutia B, Kohl A, Ghazal P, Buck AH. 2010. Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proc. Natl. Acad. Sci. U. S. A. 107: 13830-13835.
45. Pahl HL. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853- 6866.
46. Gantier MP, McCoy CE, Rusinova I, Saulep D, Wang D, Xu D, Irving AT, Behlke MA, Hertzog PJ, Mackay F, Williams BR. 2011. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 39:5692-5703.
47. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova- Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105:10513-10518.
48. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Wurdinger T, Middeldorp JM. 2010. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 107:6328-6333.
49. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY. 2008. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997-1006.
50. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K. 2010. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 70:9798 -9807.
51. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A. 2008. Serum microRNAs are promising novel biomarkers. PLoS One 3:e3148. doi:10.1371/journal.pone.0003148.
52. Playford EG, McCall B, Smith G, Slinko V, Allen G, Smith I, Moore F, Taylor C, Kung YH, Field H. 2010. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg. Infect. Dis. 16: 219-223.